Darby S C, Rizza C R, Doll R, Spooner R J, Stratton I M, Thakrar B
Imperial Cancer Research Fund Cancer Epidemiology and Clinical Trials Unit, University of Oxford, Radcliffe Infirmary.
BMJ. 1989 Apr 22;298(6680):1064-8. doi: 10.1136/bmj.298.6680.1064.
OBJECTIVE--To estimate the cumulative incidence of AIDS by time since seroconversion in haemophiliacs positive for HIV and to examine the evidence for excess mortality associated with HIV in those who had not yet been diagnosed as having AIDS. DESIGN--Analysis of data from ongoing national surveys. SETTING--Haemophilia centres in the United Kingdom. PATIENTS--A total of 1201 men with haemophilia who had lived in the United Kingdom during 1980-7 and were positive for HIV. INTERVENTION--None. END POINTS--Diagnosis of AIDS; death in those not diagnosed as having AIDS. MEASUREMENTS AND MAIN RESULTS--Estimation of cumulative incidence of AIDS and number of excess deaths in seropositive patients not diagnosed with AIDS. Median follow up after seroconversion was 5 years 2 months. Eight five patients developed AIDS. Cumulative incidence of AIDS five years after seroconversion was 4% among patients aged less than 25 at first test positive for HIV, 6% among those aged 25-44, and 19% among those aged greater than or equal to 45. There was little evidence that type or severity of haemophilia or type of factor VIII or IX that had caused HIV infection affected the rate of progression to AIDS. Mortality was increased among those who had not been diagnosed as having AIDS, especially among those with "AIDS related complex." Thirteen deaths were observed among 36 patients diagnosed as having AIDS related complex against 0.65 expected, and 34 deaths in 1080 other patients against 22.77 expected; both calculations were based on mortality rates observed in haemophiliacs in the United Kingdom in the late 1970s. CONCLUSIONS--Rate of progression to AIDS depended strongly on age. There is a substantial burden of fatal disease among patients positive for HIV who have not been formally diagnosed as having AIDS.
目的——估计HIV阳性血友病患者自血清转化以来按时间计算的艾滋病累积发病率,并研究在尚未被诊断为患有艾滋病的患者中与HIV相关的额外死亡率的证据。设计——对正在进行的全国性调查数据进行分析。地点——英国的血友病中心。患者——1980年至197年期间居住在英国且HIV呈阳性的1201名血友病男性。干预——无。终点——艾滋病诊断;未被诊断为患有艾滋病者的死亡。测量和主要结果——估计血清阳性但未被诊断为艾滋病患者的艾滋病累积发病率和额外死亡人数。血清转化后的中位随访时间为5年2个月。85名患者患上了艾滋病。在首次HIV检测呈阳性时年龄小于25岁的患者中,血清转化后5年的艾滋病累积发病率为4%,25至44岁的患者中为6%,45岁及以上的患者中为19%。几乎没有证据表明血友病的类型或严重程度或导致HIV感染的VIII或IX因子类型会影响进展为艾滋病的速度。未被诊断为患有艾滋病者的死亡率有所增加,尤其是那些患有“艾滋病相关综合征”的人。在36名被诊断为患有艾滋病相关综合征的患者中观察到13例死亡,预期为0.65例;在1080名其他患者中有34例死亡,预期为22.77例;这两种计算均基于20世纪70年代末英国血友病患者中观察到的死亡率。结论——进展为艾滋病的速度在很大程度上取决于年龄。在尚未被正式诊断为患有艾滋病的HIV阳性患者中存在相当严重致命疾病负担。